Ultimovacs ASA Financial Flexibility Index
Ultimovacs ASA financial flexibility index. Ultimovacs ASA (ULTI) has a Financial Flexibility Index of -0.74x as of December 2024. Free cash flow of Nkr-24.70 Million (operating CF Nkr-24.70 Million minus capex Nkr0.00) represents -1% of total liabilities (Nkr33.19 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ultimovacs ASA (2016–2024)
Financial flexibility index of Ultimovacs ASA from 2016 to 2024. Historical Financial Flexibility Index trend for Ultimovacs ASA across 9 annual periods. Explore ULTI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Ultimovacs ASA Financial Flexibility Index by Year (2016–2024)
Ultimovacs ASA financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Ultimovacs ASA. For the full cash flow conversion analysis, see cash flow conversion of Ultimovacs ASA.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.92x | Nkr-163.39 Million | Nkr-163.40 Million | Nkr33.19 Million | ▼ -80.6% |
| 2023 | -2.73x | Nkr-189.80 Million | Nkr-189.83 Million | Nkr69.65 Million | ▲ +1.9% |
| 2022 | -2.78x | Nkr-167.50 Million | Nkr-167.69 Million | Nkr60.32 Million | ▼ -37.8% |
| 2021 | -2.02x | Nkr-125.74 Million | Nkr-125.83 Million | Nkr62.38 Million | ▲ +22.8% |
| 2020 | -2.61x | Nkr-107.94 Million | Nkr-108.22 Million | Nkr41.34 Million | ▼ -38.9% |
| 2019 | -1.88x | Nkr-62.82 Million | Nkr-62.99 Million | Nkr33.41 Million | ▼ -12.9% |
| 2018 | -1.66x | Nkr-49.88 Million | Nkr-50.39 Million | Nkr29.96 Million | ▲ +24.4% |
| 2017 | -2.20x | Nkr-27.20 Million | Nkr-27.23 Million | Nkr12.35 Million | ▲ +50.5% |
| 2016 | -4.45x | Nkr-30.31 Million | Nkr-31.10 Million | Nkr6.81 Million | — |